LCAT and chronic kidney disease: Moreover, Baohai Shao et al. [24] discovered an association between the levels of HDL-associated proteins (including PON1, paraoxonase-3 (PON3), and lecithin cholesterol acyl transferase (LCAT)) and cardiovascular risk in chronic kidney disease patients.